394 results on '"Michonneau, David"'
Search Results
2. Donor/recipient Rh-mismatched allogeneic hematopoietic stem cell transplantation: transfusion strategy and allo-immunization to red blood cell antigens
3. Deciphering bone marrow engraftment after allogeneic stem cell transplantation in humans using single-cell analyses
4. How to decrease bone marrow collection volume and risk contaminations via the operating room cell concentration?
5. GVHD Prophylaxis
6. Systematic Review and Meta-Analysis of Extracorporeal Photopheresis for the Treatment of Steroid-Refractory Chronic Graft-Versus-Host Disease
7. Clinical and economic burden associated with graft-versus-host disease following allogeneic hematopoietic cell transplantation in France
8. A 10-year retrospective analysis of Toxoplasma gondii qPCR screening in allogeneic hematopoietic stem cell transplantation recipients
9. Interstitial lung diseases after hematopoietic stem cell transplantation: New pattern of lung chronic graft-versus-host disease?
10. Allogeneic transplantation in advanced cutaneous T-cell lymphomas (CUTALLO): a propensity score matched controlled prospective study
11. Impact of the COVID-19 pandemic on antiviral drug development for other community-acquired respiratory viruses’ infections
12. Life expectancy and burden of late complications after reduced intensity conditioning allogeneic transplantation
13. Incidence, risk factors and outcome of BK virus hemorrhagic cystitis following allogenic hematopoietic cell transplantation: a retrospective cohort study
14. Azithromycin promotes relapse by disrupting immune and metabolic networks after allogeneic stem cell transplantation
15. Graft-versus-lymphoma effect in skin after allogeneic hematopoietic stem cell transplantation for Sézary syndrome
16. Immune landscape after allo-HSCT: TIGIT- and CD161-expressing CD4 T cells are associated with subsequent leukemia relapse
17. Prospective external validation of biomarkers to predict acute graft-versus-host disease severity
18. Toward practical transparent verifiable and long-term reproducible research using Guix
19. Safety and preliminary efficacy of allogeneic bone marrow-derived multipotent mesenchymal stromal cells for systemic sclerosis: a single-centre, open-label, dose-escalation, proof-of-concept, phase 1/2 study
20. Ruxolitinib before allogeneic hematopoietic transplantation in patients with myelofibrosis on behalf SFGM-TC and FIM groups
21. Treatment Patterns and Clinical Outcomes of Patients with Moderate to Severe Acute Graft-Versus-Host Disease: A Multicenter Chart Review Study.
22. GVHD Prophylaxis (Immunosuppression)
23. Effect of Ruxolitinib on Lung Function after Allogeneic Stem Cell Transplantation
24. Human-Derived α1-Antitrypsin is Still Efficacious in Heavily Pretreated Patients with Steroid-Resistant Gastrointestinal Graft-versus-Host Disease
25. Cellular and molecular profiling of T-cell subsets at the onset of human acute GVHD
26. Should Transplantation Still Be Considered for Ph1-Negative Myeloproliferative Neoplasms in Transformation?
27. Functional and phylogenetic alterations in gut microbiome are linked to graft-versus-host disease severity
28. Azithromycin Use and Increased Cancer Risk among Patients with Bronchiolitis Obliterans after Hematopoietic Cell Transplantation
29. Long-term outcomes and risk factor analysis of steroid-refractory graft versus host disease after hematopoietic stem cell transplantation
30. Transient mTOR inhibition rescues 4-1BB CAR-Tregs from tonic signal-induced dysfunction
31. Epstein-Barr Virus-Associated Post-Transplantation Lymphoproliferative Disease in Patients Who Received Anti-CD20 after Hematopoietic Stem Cell Transplantation
32. Trajectories of acute graft-versus-host disease and mortality in critically ill allogeneic-hematopoietic stem cell recipients: the Allo-GRRR-OH score
33. Pleuroparenchymal fibroelastosis after allogeneic hematopoietic stem cell transplantation
34. A monocentric study of steroid-refractory acute graft-versus-host disease treatment with tacrolimus and mTOR inhibitor
35. CT-169 Baricitinib Treatment for Chronic Refractory Graft Versus Host Disease: A Case Report
36. POSTER: CT-169 Baricitinib Treatment for Chronic Refractory Graft Versus Host Disease: A Case Report
37. Germline HAVCR2 mutations altering TIM-3 characterize subcutaneous panniculitis-like T cell lymphomas with hemophagocytic lymphohistiocytic syndrome
38. Clinical and immune features of human parvovirus B19 infection in allogeneic stem cell transplantation recipients: A retrospective monocentric study
39. Biochemical phenotyping of paroxysmal nocturnal hemoglobinuria reveals solute carriers and β-oxidation deficiencies
40. Circulating T cell profiles associate with enterotype signatures underlying hematological malignancy relapses
41. System-level immune monitoring reveals new pathophysiological features in hepatitis-associated aplastic anemia
42. Metabolomics analysis of human acute graft-versus-host disease reveals changes in host and microbiota-derived metabolites
43. Contributors
44. In Vivo Imaging of GVHD and GVL
45. GVHD Prophylaxis (Immunosuppression)
46. Sexuality- and Fertility-Related Issues in Women after Allogeneic Hematopoietic Stem Cell Transplantation
47. Allogeneic transplantation in acute myelogenous leukemia: a comprehensive single institution's experience
48. Thrombocytapheresis and sequential chemotherapy for extreme symptomatic thrombocytosis secondary to myelofibrosis: a case report
49. 3051 – NON-GENETIC HERITABILITY OF CELL DIVISION SHAPES HUMAN HEMATOPOIESIS
50. CD24hiCD27+ and plasmablast-like regulatory B cells in human chronic graft-versus-host disease
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.